BlackRock Inc. bought a new stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,529,450 shares of the company's stock, valued at approximately $192,152,000. BlackRock Inc. owned about 16.34% of Azenta as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Conestoga Capital Advisors LLC increased its position in shares of Azenta by 116.1% during the first quarter. Conestoga Capital Advisors LLC now owns 2,844,546 shares of the company's stock worth $60,105,000 after purchasing an additional 1,528,145 shares in the last quarter. Front Street Capital Management Inc. increased its position in Azenta by 211.7% during the 1st quarter. Front Street Capital Management Inc. now owns 889,009 shares of the company's stock valued at $18,785,000 after buying an additional 603,757 shares in the last quarter. Millennium Management LLC increased its position in Azenta by 41.6% during the 3rd quarter. Millennium Management LLC now owns 1,698,562 shares of the company's stock valued at $48,783,000 after buying an additional 499,216 shares in the last quarter. Scopia Capital Management LP purchased a new stake in Azenta in the third quarter valued at about $14,026,000. Finally, Quantinno Capital Management LP raised its stake in Azenta by 192.0% in the second quarter. Quantinno Capital Management LP now owns 713,939 shares of the company's stock valued at $21,975,000 after buying an additional 469,447 shares during the last quarter. 99.08% of the stock is currently owned by institutional investors and hedge funds.
Azenta Stock Performance
Shares of AZTA opened at $33.61 on Friday. The stock has a 50-day moving average of $28.74 and a two-hundred day moving average of $25.14. The stock has a market cap of $1.47 billion, a P/E ratio of -12.18 and a beta of 1.37. Azenta, Inc. has a one year low of $15.93 and a one year high of $41.73.
Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.16 earnings per share for the quarter, beating analysts' consensus estimates of $0.11 by $0.05. Azenta had a positive return on equity of 1.18% and a negative net margin of 20.63%.The business had revenue of $161.18 million for the quarter, compared to analyst estimates of $149.31 million.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on AZTA shares. Weiss Ratings upgraded Azenta from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Wednesday. Needham & Company LLC increased their price objective on shares of Azenta from $33.00 to $37.00 and gave the company a "buy" rating in a research report on Wednesday, August 5th. Four equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $41.20.
Read Our Latest Report on Azenta
About Azenta
(
Free Report)
Azenta, Inc NASDAQ: AZTA is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.
In addition to hardware and informatics platforms for sample storage, Azenta's Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.
Featured Articles
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
